2015-2019年我国接受抗病毒治疗成年HIV/AIDS患者病死率分析  

Fatality among adult people living with HIV/AIDS who received antiretroviral therapy during 2015-2019 in China

作　　者：甘秀敏[1] 马烨[1] 赵燕[1] 吴亚松[1] 赵德才[1] GAN Xiumin;MA Ye;ZHAO Yan;WU Yasong;ZHAO Decai(National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China)

机构地区：[1]中国疾病预防控制中心性病艾滋病预防控制中心,北京102206

出　　处：《中国艾滋病性病》2021年第5期457-460,共4页Chinese Journal of Aids & STD

基　　金：国家“十三五”传染病防治科技重大专项(2017ZX10202101005-003);中国疾控中心艾防中心青年科研基金(2018AFQN006)。

摘　　要：目的分析2015-2019年期间我国接受ART成年HIV/AIDS患者病死率变化情况。方法采用连续横断面研究方法,以自然年为单位,描述性分析全国2015-2019年历年接受ART成年HIV/AIDS患者主要特征及粗病死率,并以2015年年龄构成为标准,计算历年年龄标化病死率。结果2015-2019年历年纳入分析的接受ART成年HIV/AIDS患者人数分别为416360例、515524例、623995例、755837例和885037例,其中≥50岁者占比依次为28.04%、29.48%、31.04%、33.23%和36.00%;历年接受ART成年HIV/AIDS患者中死亡人数分别为9920例、11784例、12880例、16876例和19961例,粗病死率依次为2.38%、2.29%、2.06%、2.23%和2.26%;2015-2019年年龄标化病死率依次为2.38%、2.24%、1.97%、2.06%和1.95%。结论2015-2019年期间,我国接受ART成年HIV/AIDS患者中≥50岁者占比逐年增加,死亡人数有所增长,粗病死率和年龄标化病死率均趋于平稳。Objective To analyze the fatality's major characteristics among adult people living with HIV/AIDS who received antiretroviral therapy(ART)during 2015-2019 in China.Methods We conducted a consecutive cross-sectional analysis in this study.The main characteristics of the eligible adult people living with HIV/AIDS who received ART selected from the National Treatment Database and the crude fatality during 2015-2019 were analyzed.We calculated ageadjusted fatality with a standardization process,taking the age proportion in 2015 as the standard.Results During 2015-2019,there were 416360,515524,623995,755837 and 885037 eligible adult people living with HIV/AIDS received ART included in our analysis,respectively.From 2015,the proportion of≥50 years old HIV/AIDS increased year by year with the results of 28.04%,29.48%,31.04%,33.23%and 36.00%.The death cases of the eligible adult people living with HIV/AIDS who received ART in our analysis were 9920,11784,12880,16876 and 19961,with the crude fatalities were 2.38%,2.29%,2.06%,2.23%and 2.26%,respectively.The age-adjusted fatalities were 2.38%,2.24%,1.97%,2.06%and 1.95%,respectively.Conclusions The proportion of≥50 years old among eligible adult people living with HIV/AIDS who received ART in our analysis has gradually increased year by year.The numbers of death cases also increase during 2015-2019.The crude and age-adjusted fatalities of 2015-2019 have remained relatively stable among adult people living with HIV/AIDS who received ART in China.

关 键 词：艾滋病病毒感染者/艾滋病患者 抗病毒治疗 病死率 

分 类 号：R512.91[医药卫生—内科学] R373.9[医药卫生—临床医学]